These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 34445992)

  • 1. Tinea capitis in an immigrant pediatric community; a clinical signs-based treatment approach.
    Kassem R; Shemesh Y; Nitzan O; Azrad M; Peretz A
    BMC Pediatr; 2021 Aug; 21(1):363. PubMed ID: 34445992
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The assessment and management of tinea capitis in children.
    Ali S; Graham TA; Forgie SE
    Pediatr Emerg Care; 2007 Sep; 23(9):662-5; quiz 666-8. PubMed ID: 17876261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized controlled trial assessing the efficacy of fluconazole in the treatment of pediatric tinea capitis.
    Foster KW; Friedlander SF; Panzer H; Ghannoum MA; Elewski BE
    J Am Acad Dermatol; 2005 Nov; 53(5):798-809. PubMed ID: 16243128
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tinea Capitis: An Updated Review.
    Leung AKC; Hon KL; Leong KF; Barankin B; Lam JM
    Recent Pat Inflamm Allergy Drug Discov; 2020; 14(1):58-68. PubMed ID: 31906842
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tinea capitis: epidemiology, diagnosis and management strategies.
    Pomeranz AJ; Sabnis SS
    Paediatr Drugs; 2002; 4(12):779-83. PubMed ID: 12431130
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neonatal-Onset Inflammatory Tinea Capitis by Microsporum canis Due to a Woolen Hat.
    Zou X; Chen W; Li R
    Mycopathologia; 2023 Oct; 188(5):585-587. PubMed ID: 36646941
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of tinea capitis in Israel: A comparative study.
    Shemer A; Gupta AK; Galili E; Daniel R; Kassem R; Farhi R; Grunwald H; Bamimore MA
    Pediatr Dermatol; 2021 Jul; 38(4):806-811. PubMed ID: 33998709
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Tinea capitis. Therapeutic options in the post-griseofulvin era].
    Möhrenschlager M; Korting HC; Seidl HP; Ring J; Abeck D
    Hautarzt; 2002 Dec; 53(12):788-94. PubMed ID: 12444518
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pediatric tinea capitis caused by Trichophyton violaceum and Trichophyton soudanense in Rochester, Minnesota, United States.
    Grigoryan KV; Tollefson MM; Olson MA; Newman CC
    Int J Dermatol; 2019 Aug; 58(8):912-915. PubMed ID: 30548845
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic options for the treatment of tinea capitis: griseofulvin versus fluconazole.
    Dastghaib L; Azizzadeh M; Jafari P
    J Dermatolog Treat; 2005 Feb; 16(1):43-6. PubMed ID: 15897167
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tinea capitis: advances and a needed paradigm shift.
    Le TK; Cohen BA
    Curr Opin Pediatr; 2021 Aug; 33(4):387-391. PubMed ID: 34226424
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic options for the treatment of tinea capitis caused by Trichophyton species: griseofulvin versus the new oral antifungal agents, terbinafine, itraconazole, and fluconazole.
    Gupta AK; Adam P; Dlova N; Lynde CW; Hofstader S; Morar N; Aboobaker J; Summerbell RC
    Pediatr Dermatol; 2001; 18(5):433-8. PubMed ID: 11737692
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tinea capitis update: a continuing conflict with an old adversary.
    Chen BK; Friedlander SF
    Curr Opin Pediatr; 2001 Aug; 13(4):331-5. PubMed ID: 11717558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increasing tinea capitis prevalence in Stockholm reflects immigration.
    Hällgren J; Petrini B; Wahlgren CF
    Med Mycol; 2004 Dec; 42(6):505-9. PubMed ID: 15682638
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tinea capitis.
    Gupta AK; Summerbell RC
    Med Mycol; 2000 Aug; 38(4):255-87. PubMed ID: 10975696
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systemic antifungal therapy for tinea capitis in children.
    González U; Seaton T; Bergus G; Jacobson J; Martínez-Monzón C
    Cochrane Database Syst Rev; 2007 Oct; (4):CD004685. PubMed ID: 17943825
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral griseofulvin remains the treatment of choice for tinea capitis in children.
    Bennett ML; Fleischer AB; Loveless JW; Feldman SR
    Pediatr Dermatol; 2000; 17(4):304-9. PubMed ID: 10990583
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tinea Capitis in Children Younger than Two Years Old: A Retrospective Study and Treatment Recommendations.
    Song G; Zhang M; Kong X; Liu W; Liang G
    Mycopathologia; 2023 Oct; 188(5):461-478. PubMed ID: 36581775
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improved effectiveness of an increased dose of griseofulvin for treating Tinea capitis among refugee children in Israel: A retrospective cohort study.
    Kassem R; Barzilai A; Baum S; Kempfner A; Pavlotsky F
    Mycoses; 2023 Dec; 66(12):1064-1070. PubMed ID: 37620517
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinico-myocological profile of tinea capitis in North India and response to griseofulvin.
    Singal A; Rawat S; Bhattacharya SN; Mohanty S; Baruah MC
    J Dermatol; 2001 Jan; 28(1):22-6. PubMed ID: 11280460
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.